Thyroid stimulating hormone levels at diagnosis and the L-thyroxine dose through treatment may distinguish between permanent and transient congenital hypothyroidism.
Findings do not support the routine use of thyroid hormone therapy in adults with subclinical hypothyroidism.
Excess cardiovascular disease mortality persisted for many years after thyroid-ablative treatment in patients who received radioactive iodine who did not become hypothyroid.
The rate of pre-eclampsia and preterm delivery was higher in medically managed patients with hyperparathyroidism.
Adherence to the 2015 recommendation from ATA — to use lobectomy rather than complete thyroidectomy for low-risk differentiated thyroid cancer — is increasing.
Childhood radiation-induced thyroid cancer does not affect all-cause mortality compared with healthy individuals.
The BABA robotic thyroidectomy technique appears to be safe, with excellent outcomes in benign and malignant thyroid disease.
Malignancy was more common in children with thyroid nodules classified as indeterminate by BSRTC criteria compared with adults.
Ethanol sensitization before radiofrequency ablation of benign thyroid nodules reduced time, ablation energy, and complications compared with conventional ablation.
Most imaging centers in the United States fail to analyze lateral neck lymph nodes during preoperative ultrasounds in patients with thyroid cancer.
Recombinant Human Thyrotropin vs Thyroid Hormone Withdrawal After Radioiodine Therapy in Thyroid CancerOctober 05, 2018
Outcomes after radioiodine therapy are similar after preparation with either recombinant human thyrotropin or thyroid hormone withdrawal.
Current trial evidence does not support the treatment of subclinical hypothyroidism diagnosed in pregnancy.
Total thyroxine in newborns was measured by heel-stick blood spot test.
TGF-β1and cortisol displayed both immuno-modifying and -suppressive roles with regard to thyroid autoantibodies.
Male thyroid cancer survivors have a nearly 50 percent higher risk of developing CVD than female survivors within five years of cancer diagnosis.
LOXO-292 is being evaluated in the ongoing Phase 1/2 LIBRETTO-001 clinical trial.
Compared with uninfected individuals, people with HIV controlled with combination antiretroviral therapy are not at increased risk of developing thyroid dysfunction.
Calling it 'cancer' rather than 'lesions' or 'abnormal cells' could increase anxiety, likelihood of surgery.
Investigators assessed the quality of life of patients with hypothyroidism who were treated with levothyroxine and its association to demographics and clinical symptomatology.
The associations between thyroid hormone levels, body composition, and insulin resistance in euthyroid patients with normal thyroid ultrasound findings are examined.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
There are 14 states that perform a routine second screening in infants at approximately 2 weeks of age.
Choice between total thyroidectomy or lobectomy has little effect on risk for thyroid cancer mortality.
Adolescent and young adult cancer survivors have a 73 percent higher risk of endocrine diseases.
The association between maternal thyroid function in early pregnancy and child neurodevelopment was examined.
Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.
Investigators reviewed cases of patients with multiple sclerosis treated with alemtuzumab to determine the type and frequency of thyroid dysfunction.
The device is indicated for ultrasound echo imaging, measurement, and analysis of the human body for general clinical applications including musculoskeletal, vascular, small parts (breast, thyroid), and lung imaging.
The role of low-dose levothyroxine to increase β-oxidation of fatty acids and decreases intrahepatic lipids in patients with type 2 diabetes was examined.
Postoperative Radioactive Iodine Ablation Effective in Reducing Disease Recurrence in Low-Risk Thyroid CancerJune 20, 2018
Investigators reported outcomes of a randomized phase 3 trial that assessed the use of radioactive iodine following surgical resection in patients with low-risk thyroid cancer.
Endocrinology Advisor Articles
- Heritability of BMI Stronger in Obesogenic Environments
- Maternal Gluten Intake Associated With Risk for Type 1 Diabetes in Offspring
- Bone-Derived Factors in the Treatment of Diabetes
- Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy
- Thyroid Hormone Therapy Not Beneficial for Subclinical Hypothyroidism
- Bacillus Calmette-Guerin Vaccination Lowers HbA1c in Type 1 Diabetes
- Early Manifestations, Sex Differences May Aid in Acromegaly Diagnosis
- Predictive Variables for Permanent vs Transient Congenital Hypothyroidism
- Aetna-CVS Merger Approved
- The Progression of Health Care From Personalized Medicine to Wellness Genomics and Beyond